Jane Street’s enVVeno Medical NVNO Stock Holding History

Jane Street’s Portfolio NVNO Stock Details NVNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,110	Closed	-$57.4K	–	12563
2025 Q4	$57.4K	Buy	5,110 +3,059	+149%	+$59.4K	﹤0.01%	10463
2025 Q3	$65K	Buy	2,051 +1,684	+459%	+$172K	﹤0.01%	10277
2025 Q2	$51.2K	Buy	+367	New	+$43.4K	﹤0.01%	9166
2025 Q1	–	Sell	-529	Closed	-$55.9K	–	10257
2024 Q4	$55.9K	Buy	+529	New	+$59.1K	﹤0.01%	8937
2024 Q2	–	Sell	-723	Closed	-$138K	–	9941
2024 Q1	$138K	Buy	+723	New	+$130K	﹤0.01%	8393
2021 Q2	–	Sell	-621	Closed	-$145K	–	10206
2021 Q1	$145K	Buy	+621	New	+$173K	﹤0.01%	8473
2020 Q1	–	Sell	-128	Closed	-$62K	–	5768
2019 Q4	$62K	Sell	128 -25	-16%	-$13K	﹤0.01%	4889
2019 Q3	$114K	Buy	153 +64	+72%	+$55.6K	﹤0.01%	4777
2019 Q2	$81K	Buy	+89	New	+$141K	﹤0.01%	4890
2019 Q1	–	Sell	-36	Closed	-$47K	–	5427
2018 Q4	$47K	Buy	+36	New	+$64.8K	﹤0.01%	4735
2018 Q3	–	Sell	-19	Closed	-$62K	–	5520
2018 Q2	$62K	Buy	+19	New	+$73.7K	﹤0.01%	4796

Other funds holding NVNO

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jane Street's NVNO Position: Q1 2026 in Review

Jane Street sold out of enVVeno Medical (NVNO) in Q1 2026, closing a stake of 5,110 shares — an estimated $57.4K sold.

Jane Street first reported a position in NVNO in Q2 2018 and held it in 11 quarters. The position peaked at $145K in Q1 2021. 17 funds tracked by Wall St. Rank hold NVNO as of Q1 2026.

Jane Street reported no remaining enVVeno Medical position as of Q1 2026 after selling out during the quarter.
Jane Street sold 5,110 enVVeno Medical shares in Q1 2026, an estimated $57.4K.
Jane Street first reported a position in enVVeno Medical in Q2 2018 and held it in 11 quarters.
Jane Street's enVVeno Medical position peaked at $145K in Q1 2021.
17 funds tracked by Wall St. Rank held enVVeno Medical as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.